Novo Responds to Ozempic’s Link to Rare Eye Disease

Published on December 16, 2024

Danish health authorities said on Monday they would ask the European Union’s drug regulator to review the findings of two Danish studies linking Novo Nordisk’s popular diabetes drug Ozempic to a rare sight-threatening eye condition. The two studies conducted by University of…

Read Full Article (External Site)